| Protein Name | SMAD Family Member 6 |
| Gene | SMAD6 |
| UniProt ID | O43541 |
| PDB IDs | 1NX7, 1U2U, 3WOT |
| Molecular Weight | 49 kDa |
| Subcellular Localization | Cytoplasm, nucleus |
| Protein Family | SMAD family (inhibitory) |
SMAD Family Member 6 is a SMAD family (inhibitory) member. The protein contains the characteristic domain structure including [domain descriptions]. The molecular weight is approximately 49 kDa, and the protein localizes to Cytoplasm, nucleus.
SMAD6 is an inhibitory SMAD that negatively regulates BMP and TGF-β signaling. It competes with R-SMADs for type I receptor binding and inhibits SMAD4 complex formation. SMAD6 plays important roles in bone development, cardiovascular morphogenesis, and immune regulation. In the nervous system, SMAD6 is involved in synaptic plasticity, dendritic spine formation, and neuroinflammation. It may have neuroprotective roles by limiting excessive TGF-β signaling.
SMAD6 mutations cause PHACE syndrome (posterior fossa anomalies, hemangioma, arterial lesions, cardiac defects, eye abnormalities). SMAD6 haploinsufficiency leads to neurodevelopmental disorders. In the brain, SMAD6 regulates synaptic function.
This protein is a potential therapeutic target for neurodegenerative diseases. Research is ongoing to develop small molecule inhibitors and biologics that modulate its activity.
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.